Yuki Enoki

1.8k total citations
100 papers, 1.3k citations indexed

About

Yuki Enoki is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Yuki Enoki has authored 100 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 31 papers in Epidemiology and 27 papers in Molecular Biology. Recurrent topics in Yuki Enoki's work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and Heme Oxygenase-1 and Carbon Monoxide (13 papers). Yuki Enoki is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (24 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and Heme Oxygenase-1 and Carbon Monoxide (13 papers). Yuki Enoki collaborates with scholars based in Japan, Australia and Malaysia. Yuki Enoki's co-authors include Hiroshi Watanabe, Kazuaki Matsumoto, Kazuaki Taguchi, Toru Maruyama, Masaki Otagiri, Yu Ishima, Masafumi Fukagawa, Kazutaka Matsushita, Motoko Tanaka and Tadashi Imafuku and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yuki Enoki

90 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Enoki Japan 18 314 298 284 238 231 100 1.3k
Laetitia Koppe France 23 706 2.2× 682 2.3× 146 0.5× 742 3.1× 76 0.3× 60 1.9k
Hassan Argani Iran 25 336 1.1× 181 0.6× 56 0.2× 283 1.2× 109 0.5× 113 1.8k
Sylvie Saivin France 23 160 0.5× 107 0.4× 112 0.4× 136 0.6× 600 2.6× 75 1.7k
Anne Zanchi Switzerland 22 374 1.2× 391 1.3× 136 0.5× 208 0.9× 82 0.4× 82 1.6k
Fredrik Sjövall Sweden 16 343 1.1× 115 0.4× 202 0.7× 75 0.3× 675 2.9× 51 1.5k
Donald F. Brophy United States 24 207 0.7× 82 0.3× 177 0.6× 150 0.6× 88 0.4× 88 2.2k
Won Yong Cho South Korea 27 639 2.0× 175 0.6× 99 0.3× 852 3.6× 68 0.3× 90 2.4k
Stéphanie Badiou France 23 236 0.8× 198 0.7× 173 0.6× 232 1.0× 32 0.1× 112 1.4k
Emanuele Rezoagli Italy 24 297 0.9× 126 0.4× 85 0.3× 69 0.3× 125 0.5× 106 1.7k
Andréa Emília Marques Stinghen Brazil 23 356 1.1× 239 0.8× 61 0.2× 758 3.2× 67 0.3× 61 1.6k

Countries citing papers authored by Yuki Enoki

Since Specialization
Citations

This map shows the geographic impact of Yuki Enoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Enoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Enoki more than expected).

Fields of papers citing papers by Yuki Enoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Enoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Enoki. The network helps show where Yuki Enoki may publish in the future.

Co-authorship network of co-authors of Yuki Enoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Enoki. A scholar is included among the top collaborators of Yuki Enoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Enoki. Yuki Enoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishimura, Tomoyasu, Maiko Yoshikawa, Yuki Enoki, et al.. (2025). Combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro. Journal of Global Antimicrobial Resistance. 42. 142–150.
2.
3.
Matsumoto, Kazuaki, et al.. (2024). Antimicrobial Stewardship of Oral Third-Generation Cephalosporins in Community Pharmacy: A Single-Center Quasi-Experimental Study. Biological and Pharmaceutical Bulletin. 47(8). 1447–1451. 1 indexed citations
4.
Taguchi, Kazuaki, et al.. (2024). Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysis. Journal of Antimicrobial Chemotherapy. 80(2). 547–553. 1 indexed citations
5.
Takada, Keisuke, Naoki Hirose, Fumio Nagumo, et al.. (2023). Comparison of the efficacy and safety of standard‐ and high‐dose daptomycin: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 89(4). 1291–1303. 4 indexed citations
6.
Suzuki, Yuto, et al.. (2023). Pharmaceutical stability of methemoglobin-albumin cluster as an antidote for hydrogen sulfide poisoning after one-year storage in freeze-dried form. International Journal of Pharmaceutics. 645. 123433–123433. 2 indexed citations
7.
8.
Suzuki, Yuto, et al.. (2023). Elucidating the binding properties of methemoglobin in red blood cell to cyanide, hydrosulfide, and azide ions using artificial red blood cell. Toxicology and Applied Pharmacology. 481. 116752–116752. 1 indexed citations
9.
Chuang, Victor Tuan Giam, et al.. (2023). The anti-inflammatory effect of tedizolid on carrageenan-induced footpad edema rat model. Journal of Infection and Chemotherapy. 29(11). 1088–1090. 1 indexed citations
10.
11.
Namkoong, Ho, Koichi Fukunaga, Yuki Enoki, et al.. (2022). Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system. BMC Infectious Diseases. 22(1). 580–580. 4 indexed citations
12.
13.
Yoshikawa, Gakushi, et al.. (2022). Influences of protein levels on the cerebrospinal fluid distribution of ceftazidime & ceftriaxone in the cerebrospinal fluid of patients with inflamed meningitis. Journal of Infection and Chemotherapy. 28(8). 1216–1219. 2 indexed citations
14.
Liu, Xiaoxi, et al.. (2022). Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA. Pharmaceutical Research. 40(1). 187–196. 8 indexed citations
15.
Mizukami, Yuki, Yuki Enoki, Kazuaki Taguchi, et al.. (2021). The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses. Journal of Infection and Chemotherapy. 27(5). 781–785. 4 indexed citations
16.
Hirose, Naoki, Junichi Ishii, Fumio Nagumo, et al.. (2019). Support for fungal infection treatment mediated by pharmacist-led antifungal stewardship activities. Journal of Infection and Chemotherapy. 26(3). 272–279. 20 indexed citations
17.
Watanabe, Hiroshi, Hitoshi Maeda, Keisuke Hamasaki, et al.. (2018). Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery. Journal of Controlled Release. 277. 23–34. 26 indexed citations
18.
Sugimoto, Ryusei, Hiroshi Watanabe, Yuki Enoki, et al.. (2016). Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. Kidney International. 91(3). 658–670. 40 indexed citations
19.
Enoki, Yuki, Hiroshi Watanabe, Ryusei Sugimoto, et al.. (2016). Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1. Scientific Reports. 6(1). 32084–32084. 146 indexed citations
20.
Tanaka, Ryota, Yu Ishima, Yuki Enoki, et al.. (2014). Therapeutic Impact of Human Serum Albumin–Thioredoxin Fusion Protein on Influenza Virus-Induced Lung Injury Mice. Frontiers in Immunology. 5. 561–561. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laetitia Koppe Breakdown of academic impact, for papers by Hassan Argani Breakdown of academic impact, for papers by Sylvie Saivin Breakdown of academic impact, for papers by Anne Zanchi Breakdown of academic impact, for papers by Fredrik Sjövall Breakdown of academic impact, for papers by Donald F. Brophy Breakdown of academic impact, for papers by Won Yong Cho Breakdown of academic impact, for papers by Stéphanie Badiou Breakdown of academic impact, for papers by Emanuele Rezoagli Breakdown of academic impact, for papers by Andréa Emília Marques Stinghen
Rankless by CCL
2026